These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8683245)

  • 1. p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions.
    Kurvinen K; Syrjänen K; Syrjänen S
    J Clin Oncol; 1996 Jul; 14(7):2120-30. PubMed ID: 8683245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix.
    Grace VM; Shalini JV; lekha TT; Devaraj SN; Devaraj H
    Gynecol Oncol; 2003 Oct; 91(1):51-8. PubMed ID: 14529662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk human papillomavirus infection and E6 protein expression in lesions of the uterine cervix.
    Pillai MR; Lakshmi S; Sreekala S; Devi TG; Jayaprakash PG; Rajalakshmi TN; Devi CG; Nair MK; Nair MB
    Pathobiology; 1998; 66(5):240-6. PubMed ID: 9732239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of expression of apoptosis-related proteins and their correlation with HPV, telomerase activity, and apoptotic index in cervical cancer.
    Singh A; Sharma H; Salhan S; Gupta SD; Bhatla N; Jain SK; Singh N
    Pathobiology; 2004; 71(6):314-22. PubMed ID: 15627842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18.
    Akasofu M; Oda Y
    Virchows Arch; 1995; 425(6):593-602. PubMed ID: 7697216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased programmed cell death in the uterine cervix associated with high risk human papillomavirus infection.
    Nair P; Nair KM; Jayaprakash PG; Pillai MR
    Pathol Oncol Res; 1999; 5(2):95-103. PubMed ID: 10393359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
    Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
    Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p53, MDM2, and p21 proteins in high-grade cervical intraepithelial neoplasia and relationship to human papillomavirus infection.
    Lie AK; Skarsvåg S; Skomedal H; Haugen OA; Holm R
    Int J Gynecol Pathol; 1999 Jan; 18(1):5-11. PubMed ID: 9891236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression of p53 and Bcl-2 proteins in human papillomavirus-induced premalignant lesions of the uterine cervix: correlation with progression to malignancy.
    Singh M; Srivastava S; Singh U; Mathur N; Shukla Y
    Tumour Biol; 2009; 30(5-6):276-85. PubMed ID: 19940548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a condemned mucosa syndrome and pathogenesis of human papillomavirus-associated upper aerodigestive tract and uterine cervical tumors.
    Pillai MR; Nair MK
    Exp Mol Pathol; 2000 Dec; 69(3):233-41. PubMed ID: 11115364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
    Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased angiogenesis in the uterine cervix associated with human papillomavirus infection.
    Nair P; Gangadevi T; Jayaprakash PG; Nair MB; Nair MK; Pillai MR
    Pathol Res Pract; 1999; 195(3):163-9. PubMed ID: 10220796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillomavirus, p53 alteration, and primary carcinoma of the vulva.
    Pilotti S; D'Amato L; Della Torre G; Donghi R; Longoni A; Giarola M; Sampietro G; De Palo G; Pierotti MA; Rilke F
    Diagn Mol Pathol; 1995 Dec; 4(4):239-48. PubMed ID: 8634779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival.
    Bahnassy AA; Zekri AR; Abdallah S; El-Shehaby AM; Sherif GM
    Pathol Int; 2005 Feb; 55(2):53-62. PubMed ID: 15693850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
    Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
    Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase, p53 and human papillomavirus infection in the uterine cervix.
    Nair P; Jayaprakash PG; Nair MK; Pillai MR
    Acta Oncol; 2000; 39(1):65-70. PubMed ID: 10752656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of mdm2 and p21WAF1 in invasive cervical cancer: correlation with p53 protein and high risk HPV infection.
    Troncone G; Martinez JC; Palombini L; De Rosa G; Mugica C; Rodriguez JA; Zeppa P; Di Vizio D; Lucariello A; Piris MA
    J Clin Pathol; 1998 Oct; 51(10):754-60. PubMed ID: 10023338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia.
    Sano T; Masuda N; Oyama T; Nakajima T
    Pathol Int; 2002; 52(5-6):375-83. PubMed ID: 12100520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemosensitivity and p53-Bax pathway-mediated apoptosis in patients with uterine cervical cancer.
    Sultana H; Kigawa J; Kanamori Y; Itamochi H; Oishi T; Sato S; Kamazawa S; Ohwada M; Suzuki M; Terakawa N
    Ann Oncol; 2003 Feb; 14(2):214-9. PubMed ID: 12562647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.